Recto-vaginal Fistula Treatment Market

Recto-vaginal Fistula Treatment Market (Type: High Recto-vaginal Fistula, Low Recto-vaginal Fistula, and Midzone Fistula; End-user; Indication and Treatment) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Recto-vaginal Fistula Treatment Market Outlook 2031

  • The global recto-vaginal fistula treatment market was valued at US$ 550.8 Mn in 2020
  • It is estimated to expand at a CAGR of 5.7% from 2021 to 2031
  • The global recto-vaginal fistula treatment market is expected to cross the value of US$ 1 Bn by the end of 2031

Analysts’ Viewpoint on Recto-vaginal Fistula Treatment Market Scenario

Elective procedures have been postponed indefinitely in the recto-vaginal fistula treatment market due to the ongoing coronavirus pandemic. Healthcare stakeholders are increasing the availability of tests such as contrast tests, blue dye test, and CT scan to identify fistulas. However, the high number of morbidity and mortality even after recto-vaginal fistula treatment is emerging as a challenge to healthcare practitioners. Hence, practitioners should increase awareness about pre-appointment restrictions, considerations for surgery and listing key medical information to enable proper diagnosis of recto-vaginal fistula. It has been found that presence of cancerous tumor in regions such as uterus, rectum, vagina, anal canal or cervix, can lead to the development of recto-vaginal fistula.

Childbirth Injuries and Crohn’s Disease Fuel Demand for Recto-vaginal Fistula Treatment Options

The rise in prevalence of Crohn’s disease resulting in the occurrence of recto-vaginal fistula is driving the global recto-vaginal fistula treatment market. Crohn's disease can be defined as an inflammatory bowel disease, wherein there is an inflammation of the digestive tract lining. A large number of women suffering from Crohn’s disease never develop recto-vaginal fistula. However, suffering from Crohn’s disease increases the risk of this condition. Hence, the prevalence of recto-vaginal fistula is projected to rise during the forecast period, owing to the increase in incidence of Crohn’s disease.

Delivery-related injuries is a most common factor causing recto-vaginal fistulas. This includes perineum tear that extends to the bowel or an episiotomy infection, which is a surgical incision conducted to enlarge the perineum during the course of vaginal delivery. These could occur post a long, difficult, or otherwise obstructed labor. These kinds of fistula could also comprise injury to anal sphincter, the muscle rings at the end of the rectum that aids a person to hold. Hence, the incidence rate of recto-vaginal fistula is likely to increase due to rise in the rate of childbirth injuries during the forecast period. Such findings are steering the growth of the recto-vaginal fistula treatment market.

Request a sample to get extensive insights into the Recto-vaginal Fistula Treatment Market

Home Remedies and Telehealth Ensure Revenue Growth Post COVID-19 Pandemic

Stakeholders in the recto-vaginal fistula treatment market are adopting contingency planning to prevent disruption across patient demands, supply of materials, and availability of diagnostic services. Since elective procedures have been postponed indefinitely due to the ongoing coronavirus pandemic, medical practitioners are increasing awareness about different tests for identifying fistulas, medications, and lifestyle or home remedies to reduce burden on healthcare facilities. As such, telehealth and mobile apps are anticipated to register high growth post the pandemic. Healthcare stakeholders are striking a balanced relationship with suppliers and ecosystem partners to improve medical outcomes. They are increasing the availability of life-altering therapeutics.

To understand how our report can bring difference to your business strategy, Ask for a brochure

Healthcare Stakeholders Invest in R&D to Increase Treatment Options

Recto-vaginal fistula can be described as abnormal epithelial line connected between the rectum and vagina. Fistulas can be the outcome of acquired etiologies or congenital malformations. Recto-vaginal fistulas can also be caused due to childbirth. Obstetric injury with a fourth or a third degree perineal tear or prolonged labor with necrosis of the part or episiotomy could result in recto-vaginal fistula. Infection, breakdown of the repair, or improper repair can lead to the development of fistula. Infections caused within the recto-vaginal septum can lead to the condition. Bartholin gland infections and crypto-glandular ano-rectal abscess drains cause low recto-vaginal fistula. This explains why the recto-vaginal fistula treatment market is positioned for healthy growth during the forecast period.

Hysterectomy is performed as a result of infection caused due to fistula. Lymph granuloma venereum and tuberculosis can result in recto-vaginal fistula. Primary classification of the condition is carried out with the help of etiology, size, and location. It categorizes the criteria for recto-vaginal fistulas as complex or simple. Classification of fistula is performed to plan proper treatment and appropriate therapy. Fistulas greater than 2.5 cm in diameter are termed as large and those less than 2.5 cm are considered small. Hence, healthcare practitioners in the recto-vaginal fistula treatment market are increasing R&D to boost availability of therapeutics.

Stuck in a neck-to-neck competition with other brands? Request a custom report on Recto-vaginal Fistula Treatment Market

Robust Healthcare Infrastructure in North America Helps Increase Patient Outcomes

North America is anticipated to dominate the global recto-vaginal fistula treatment market from 2021 to 2031. This can be attributed to favorable regulatory environment, rise in focus and interest in recto-vaginal fistula research & development (R&D), and government funding for life sciences research. Additionally, well-established and high quality infrastructure are driving the North America recto-vaginal fistula treatment market. The market in Asia Pacific is expected to grow at a rapid pace during the forecast period due to rise in R&D activities, increase in government initiatives for improving healthcare, and surge in focus of key players on building or strengthening presence in the region.

Governments of developing countries are making significant investments to modernize healthcare infrastructure in their respective countries, which is likely to increase access to healthcare. This is projected to fuel the demand for recto-vaginal fistula treatment.

Recto-vaginal Fistula Treatment Market: Overview

  • Recto-vaginal fistula is an abnormal connection between lower portions of large intestine-rectum-vagina. Causes of rectovaginal fistula include Crohn's disease, cancer or radiation treatment in pelvic area, surgery involving vagina, perineum, rectum or anus, and injuries during childbirth.
  • Fistula connects to surfaces or lumens. It begins on the offending side and makes its way to an adjacent lumen or surface. It follows the easiest and shortest path to the adjacent organ. Recto-vaginal fistula starts from the rectum and extends to the vagina. It is not a healthy situation or physiological status. There is usually an underlying pathology, injury, or surgical event. Characteristics of rectovaginal fistula (RVF), such as site, size, length, activity, and symptoms, vary depending on the cause of the fistula, patient factors, and the treatment received. It is a potentially challenging surgical condition for both the patient and the healthcare team. The underlying etiology determines the method of assessment, management, and prognosis.
  • The frequency of recto-vaginal fistula varies according to the cause. These are typically classified by etiology, location, and size, which affect the treatment and prognosis. Recto-vaginal fistulas are divided into two groups by location:
  • Low RVFs are located in the lower third of the rectum and the lower half of the vagina. These are closest to the anus and are repaired with a perineal surgical approach.
  • High RVFs are located between the middle third of the rectum and the posterior vaginal fornix. These require a transabdominal surgical repair approach.
  • Most RVFs are less than 2 cm in diameter and are stratified by size:
    • Small: Less than 0.5 cm in diameter
    • Medium-sized: 0.5 to 2.5 cm in diameter
    • Large RVFs: Exceed 2.5 cm in diameter

Recto-vaginal Fistula Treatment Market: Drivers

  • Rise in prevalence of Crohn’s disease leading to the occurrence of recto-vaginal fistula drives the global recto-vaginal fistula treatment market. Crohn's disease can be defined as an inflammatory bowel disease, wherein there is an inflammation of the digestive tract lining. Large number of women suffering from Crohn’s disease never develop recto-vaginal fistula. However, Crohn’s disease increases the risk of this condition. Hence, prevalence of recto-vaginal fistula is projected to rise during the forecast period owing to increase in incidence of Crohn’s disease.
  • Delivery-related injuries is the most common factor causing recto-vaginal fistulas. This includes perineum tear that extends to the bowel or an episiotomy infection, which is a surgical incision conducted to enlarge the perineum during the course of vaginal delivery. These could occur post a long, difficult, or otherwise obstructed labor. These kinds of fistula could also comprise injury to anal sphincter, the muscle rings at the end of the rectum that aid a person to hold. Hence, the incidence rate of recto-vaginal fistula is likely to increase due to rise in the rate of childbirth injuries during the forecast period.
  • Presence of cancerous tumor in regions, such as uterus, rectum, vagina, anal canal or cervix, can lead to development of recto-vaginal fistula. Moreover, radiation therapy undertaken to treat cancer in these body parts increases the risk of development of recto-vaginal fistulas. Past surgery in lower pelvic region, such as hysterectomy, could also result in development of recto-vaginal fistula. Therefore, rise in prevalence of pelvic cancer and surgery in lower pelvic region are projected to drive the global recto-vaginal fistula market.

Market Segmentation: Recto-vaginal Fistula Treatment Market

  • In terms of type, the global recto-vaginal fistula treatment market has been classified into high rectovaginal fistula, low rectovaginal fistula, and midzone fistula
  • Based on end-user, the global Rectovaginal fistula treatment market has been categorized into hospitals, ambulatory surgical centers, and others
  • In terms of treatment, the global recto-vaginal fistula treatment market has been bifurcated into medication and surgery
  • Based on indication, the global recto-vaginal fistula treatment market has been divided into Crohn's disease, delivery-related injuries, cancerous tumor treatment, and others
  • Each of the segments has been analyzed in detail for market trends, recent trends, and developments, drivers, restraints, opportunities, and useful insights. The Recto-vaginal fistula treatment market report provides current and expected revenue (US$ Mn) for each of these segments from 2021 to 2031, considering 2020 as the base year. The compound annual growth rate (percentage CAGR) has been provided for each segment and market from 2021 to 2031 along with market size estimations.

Regional Overview: Recto-vaginal Fistula Treatment Market

  • In terms of region, the global recto-vaginal fistula treatment market has been segmented into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa
  • The recto-vaginal fistula treatment market in North America was valued at US$ 148.7 Mn in 2020 and is projected to reach US$ 325.8 Mn by 2031, expanding at a CAGR of 7.2% from 2021 to 2031
  • Growth of the market in the region can be attributed to favorable regulatory environment, rise in focus and interest in recto-vaginal fistula research & development, and government funding for life sciences research. Additionally, well-established and high quality infrastructure drives the market in North America.

Major Players: Recto-vaginal Fistula Treatment Market

  • The recto-vaginal fistula treatment market report concludes with the company profiles section, which includes key information about major players in the global recto-vaginal fistula treatment market
  • Leading players analyzed in the report include Pfizer, Inc., GlaxoSmithKline plc, Sanofi S.A., Takeda Pharmaceutical Company Limited, Johnson & Johnson Services, Inc., W. L. Gore & Associates, Inc., Mount Sinai Hospital, Tubingen University Hospital, St. Mark's Hospital, Apollo Hospitals Enterprise Ltd., and other prominent players
  • Each of these players has been profiled in the recto-vaginal fistula treatment market report based on parameters such as company overview, financial overview, business strategies, application portfolio, business segments, and recent developments

Recto-vaginal Fistula Treatment Market Snapshot

Attribute

Detail

Market Size Value in 2020

US$ 550.8 Mn

Market Forecast Value in 2031

US$ 1,034.3 Mn

Growth Rate (CAGR)

5.7%

Forecast Period

2021–2031

Quantitative Units

US$ Mn for Value

Market Analysis

It includes cross segment analysis at global as well as regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview.

Competition Landscape

  • Market player - Competition Matrix (by tier and size of companies)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Market Segmentation

  • By Type
    • High Recto-vaginal Fistula
    • Low Recto-vaginal Fistula
    • Midzone Fistula
  • By End-user
    • Hospitals
    • Ambulatory Surgical Centers
    • Others
  • By Indication
    • Crohn's Disease
    • Delivery-related Injuries
    • Cancerous Tumor Treatment
    • Others
  • By Treatment
    • Medication
      • Antibiotics
      • Biologics Therapy
    • Surgery
      • Sphincteroplasty Procedure
      • Endorectal Advancement Flap Procedure
      • Others

Regions Covered

  • North America
  • Latin America
  • Europe
  • Latin America
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Companies Profiled

  • Pfizer, Inc.
  • GlaxoSmithKline plc
  • Sanofi S.A.
  • Takeda Pharmaceutical Company Limited
  • Johnson & Johnson Services, Inc.
  • W. L. Gore & Associates, Inc.
  • Mount Sinai Hospital
  • Tubingen University Hospital
  • St. Mark's Hospital
  • Apollo Hospitals Enterprise Ltd.
  • Other prominent players

Customization Scope

Available upon request

Pricing

Available upon request

Recto-vaginal Fistula Treatment Market – Segmentation

TMR’s study on the global recto-vaginal fistula treatment market includes information divided into three segments: type, end-user, indication, treatment, and region. Changing industry trends and other market dynamics associated with these segments of the global recto-vaginal fistula treatment market are discussed in detail.

Type
  • High Recto-vaginal Fistula
  • Low Recto-vaginal Fistula
  • Midzone Fistula
End-user
  • Hospitals
  • Ambulatory Surgical Center
  • Others
Indication
  • Crohn's Disease
  • Delivery-related Injuries
  • Cancerous Tumor Treatment
  • Others
Treatment
  • Medication
    • Antibiotics
    • Biologics Therapy
  • Surgery
    • Sphincteroplasty Procedure
    • Endorectal Advancement Flap Procedure
    • Others
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Frequently Asked Questions

What is the total market worth of recto-vaginal fistula treatment market?

Recto-vaginal fistula treatment market is expected to cross the value of US$ 1 Bn by the end of 2031

What is the anticipated CAGR of the recto-vaginal fistula treatment market in the forecast period?

Recto-vaginal fistula treatment market is estimated to expand at a CAGR of 5.7% from 2021 to 2031

What are the key driving factors for the growth of the recto-vaginal fistula treatment market?

Recto-vaginal fistula treatment market is driven by rise in prevalence of Crohn’s disease resulting in the occurrence of recto-vaginal fistula.

Which is the rising prominent segment in the recto-vaginal fistula treatment market?

The high recto-vaginal fistula segment is projected to account for major share of the market by 2031

Who are the key players in the global recto-vaginal fistula treatment market?

Key players operating in the global market include Pfizer, Inc., GlaxoSmithKline plc, Sanofi S.A., Takeda Pharmaceutical Company Limited, Johnson & Johnson Services, Inc.

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Recto-vaginal Fistula Treatment Market

    4. Market Overview

        4.1. Introduction

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Recto-vaginal Fistula Treatment Market Analysis and Forecast, 2017–2031

            4.4.1. Market Revenue Projections (US$ Mn)

    5. Key Insights

        5.1. Advancements & Innovations in Treatment Methods/Medications

        5.2. Disease Epidemiology Analysis

        5.3. Key Industry Events (mergers, acquisitions, agreements / partnerships, etc.)

        5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

    6. Global Recto-vaginal Fistula Treatment Market Analysis and Forecast, by Type

        6.1. Introduction & Definition

        6.2. Key Findings / Developments

        6.3. Market Value Forecast, by Type, 2017–2031

            6.3.1. High Recto-vaginal Fistula

            6.3.2. Low Recto-vaginal Fistula

            6.3.3. Midzone Fistula

        6.4. Market Attractiveness Analysis, by Type

    7. Global Recto-vaginal Fistula Treatment Market Analysis and Forecast, by End-user

        7.1. Introduction & Definition

        7.2. Key Findings / Developments

        7.3. Market Value Forecast, by End-user, 2017–2031

            7.3.1. Hospitals

            7.3.2. Ambulatory Surgical Centers

            7.3.3. Others

        7.4. Market Attractiveness Analysis, by End-user

    8. Global Recto-vaginal Fistula Treatment Market Analysis and Forecast, by Treatment

        8.1. Introduction & Definition

        8.2. Key Findings / Developments

        8.3. Market Value Forecast, by Treatment, 2017–2031

            8.3.1. Medication

                8.3.1.1. Antibiotics

                8.3.1.2. Biologics Therapy

            8.3.2. Surgery

                8.3.2.1. Sphincteroplasty Procedure

                8.3.2.2. Endorectal Advancement Flap Procedure

                8.3.2.3. Others

        8.4. Market Attractiveness Analysis, by Treatment

    9. Global Recto-vaginal Fistula Treatment Market Analysis and Forecast, by Indication

        9.1. Introduction & Definition

        9.2. Key Findings / Developments

        9.3. Market Value Forecast, by Indication, 2017–2031

            9.3.1. Crohn's Disease

            9.3.2. Delivery-related Injuries

            9.3.3. Cancerous Tumor Treatment

            9.3.4. Others

        9.4. Market Attractiveness Analysis, by Indication

    10. Global Recto-vaginal Fistula Treatment Market Analysis and Forecast, by Region

        10.1. Key Findings

        10.2. Market Value Forecast, by Region

            10.2.1. North America

            10.2.2. Europe

            10.2.3. Asia Pacific

            10.2.4. Latin America

            10.2.5. Middle East & Africa

        10.3. Market Attractiveness Analysis, by Country/Region

    11. North America Recto-vaginal Fistula Treatment Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Market Value Forecast, by Type, 2017–2031

            11.2.1. High Recto-vaginal Fistula

            11.2.2. Low Recto-vaginal Fistula

            11.2.3. Midzone Fistula

        11.3. Market Value Forecast, by End-user, 2017–2031

            11.3.1. Hospitals

            11.3.2. Ambulatory Surgical Centers

            11.3.3. Others

        11.4. Market Value Forecast, by Treatment, 2017–2031

            11.4.1. Medication

                11.4.1.1. Antibiotics

                11.4.1.2. Biologics Therapy

            11.4.2. Surgery

                11.4.2.1. Sphincteroplasty Procedure

                11.4.2.2. Endorectal Advancement Flap Procedure

                11.4.2.3. Others

        11.5. Market Value Forecast, by Indication, 2017–2031

            11.5.1. Crohn's Disease

            11.5.2. Delivery-related Injuries

            11.5.3. Cancerous Tumor Treatment

            11.5.4. Others

        11.6. Market Value Forecast, by Country, 2017–2031

            11.6.1. U.S.

            11.6.2. Canada

        11.7. Market Attractiveness Analysis

            11.7.1. By Type

            11.7.2. By End-user

            11.7.3. By Treatment

            11.7.4. By Indication

            11.7.5. By Country

    12. Europe Recto-vaginal Fistula Treatment Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value Forecast, by Type, 2017–2031

            12.2.1. High Recto-vaginal Fistula

            12.2.2. Low Recto-vaginal Fistula

            12.2.3. Midzone Fistula

        12.3. Market Value Forecast, by End-user, 2017–2031

            12.3.1. Hospitals

            12.3.2. Ambulatory Surgical Centers

            12.3.3. Others

        12.4. Market Value Forecast, by Treatment, 2017–2031

            12.4.1. Medication

                12.4.1.1. Antibiotics

                12.4.1.2. Biologics Therapy

            12.4.2. Surgery

                12.4.2.1. Sphincteroplasty Procedure

                12.4.2.2. Endorectal Advancement Flap Procedure

                12.4.2.3. Others

        12.5. Market Value Forecast, by Indication, 2017–2031

            12.5.1. Crohn's Disease

            12.5.2. Delivery-related Injuries

            12.5.3. Cancerous Tumor Treatment

            12.5.4. Others

        12.6. Market Value Forecast, by Country/Sub-region, 2017–2031

            12.6.1. Germany

            12.6.2. U.K.

            12.6.3. France

            12.6.4. Italy

            12.6.5. Spain

            12.6.6. Rest of Europe

        12.7. Market Attractiveness Analysis

            12.7.1. By Type

            12.7.2. By End-user

            12.7.3. By Treatment

            12.7.4. By Indication

            12.7.5. By Country/Sub-region

    13. Asia Pacific Recto-vaginal Fistula Treatment Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value Forecast, by Type, 2017–2031

            13.2.1. High Recto-vaginal Fistula

            13.2.2. Low Recto-vaginal Fistula

            13.2.3. Midzone Fistula

        13.3. Market Value Forecast, by End-user, 2017–2031

            13.3.1. Hospitals

            13.3.2. Ambulatory Surgical Centers

            13.3.3. Others

        13.4. Market Value Forecast, by Treatment, 2017–2031

            13.4.1. Medication

                13.4.1.1. Antibiotics

                13.4.1.2. Biologics Therapy

            13.4.2. Surgery

                13.4.2.1. Sphincteroplasty Procedure

                13.4.2.2. Endorectal Advancement Flap Procedure

                13.4.2.3. Others

        13.5. Market Value Forecast, by Indication, 2017–2031

            13.5.1. Crohn's Disease

            13.5.2. Delivery-related Injuries

            13.5.3. Cancerous Tumor Treatment

            13.5.4. Others

        13.6. Market Value Forecast, by Country/Sub-region, 2017–2031

            13.6.1. Japan

            13.6.2. China

            13.6.3. India

            13.6.4. Australia & New Zealand

            13.6.5. Rest of APAC

        13.7. Market Attractiveness Analysis

            13.7.1. By Type

            13.7.2. By End-user

            13.7.3. By Treatment

            13.7.4. By Indication

            13.7.5. By Country/Sub-region

    14. Latin America Recto-vaginal Fistula Treatment Market Analysis and Forecast

        14.1. Introduction

            14.1.1. Key Findings

        14.2. Market Value Forecast, by Type, 2017–2031

            14.2.1. High Recto-vaginal Fistula

            14.2.2. Low Recto-vaginal Fistula

            14.2.3. Midzone Fistula

        14.3. Market Value Forecast, by End-user, 2017–2031

            14.3.1. Hospitals

            14.3.2. Ambulatory Surgical Centers

            14.3.3. Others

        14.4. Market Value Forecast, by Treatment, 2017–2031

            14.4.1. Medication

                14.4.1.1. Antibiotics

                14.4.1.2. Biologics Therapy

            14.4.2. Surgery

                14.4.2.1. Sphincteroplasty Procedure

                14.4.2.2. Endorectal Advancement Flap Procedure

                14.4.2.3. Others

        14.5. Market Value Forecast, by Indication, 2017–2031

            14.5.1. Crohn's Disease

            14.5.2. Delivery-related Injuries

            14.5.3. Cancerous Tumor Treatment

            14.5.4. Others

        14.6. Market Value Forecast, by Country/Sub-region, 2017–2031

            14.6.1. Brazil

            14.6.2. Mexico

            14.6.3. Rest of LATAM

        14.7. Market Attractiveness Analysis

            14.7.1. By Type

            14.7.2. By End-user

            14.7.3. By Treatment

            14.7.4. By Indication

            14.7.5. By Country/Sub-region

    15. Middle East & Africa Recto-vaginal Fistula Treatment Market Analysis and Forecast

        15.1. Introduction

            15.1.1. Key Findings

        15.2. Market Value Forecast, by Type, 2017–2031

            15.2.1. High Recto-vaginal Fistula

            15.2.2. Low Recto-vaginal Fistula

            15.2.3. Midzone Fistula

        15.3. Market Value Forecast, by End-user, 2017–2031

            15.3.1. Hospitals

            15.3.2. Ambulatory Surgical Centers

            15.3.3. Others

        15.4. Market Value Forecast, by Treatment, 2017–2031

            15.4.1. Medication

                15.4.1.1. Antibiotics

                15.4.1.2. Biologics Therapy

            15.4.2. Surgery

                15.4.2.1. Sphincteroplasty Procedure

                15.4.2.2. Endorectal Advancement Flap Procedure

                15.4.2.3. Others

        15.5. Market Value Forecast, by Indication, 2017–2031

            15.5.1. Crohn's Disease

            15.5.2. Delivery-related Injuries

            15.5.3. Cancerous Tumor Treatment

            15.5.4. Others

        15.6. Market Value Forecast, by Country/Sub-region, 2017–2031

            15.6.1. GCC Countries

            15.6.2. South Africa

            15.6.3. Rest of MEA

        15.7. Market Attractiveness Analysis

            15.7.1. By Type

            15.7.2. By End-user

            15.7.3. By Treatment

            15.7.4. By Indication

            15.7.5. By Country/Sub-region

    16. Competition Landscape

        16.1. Market Player – Competition Matrix (by tier and size of companies)

        16.2. Company Profiles

            16.2.1. Pfizer Inc.

                16.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.1.2. Company Financials

                16.2.1.3. Growth Strategies

                16.2.1.4. SWOT Analysis

            16.2.2. GlaxoSmithKline plc

                16.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.2.2. Company Financials

                16.2.2.3. Growth Strategies

                16.2.2.4. SWOT Analysis

            16.2.3. Sanofi S.A.

                16.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.3.2. Company Financials

                16.2.3.3. Growth Strategies

                16.2.3.4. SWOT Analysis

            16.2.4. Takeda Pharmaceutical Company Limited

                16.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.4.2. Company Financials

                16.2.4.3. Growth Strategies

                16.2.4.4. SWOT Analysis

            16.2.5. Johnson & Johnson Services, Inc.

                16.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.5.2. Company Financials

                16.2.5.3. Growth Strategies

                16.2.5.4. SWOT Analysis

            16.2.6. W. L. Gore & Associates, Inc.

                16.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.6.2. Company Financials

                16.2.6.3. Growth Strategies

                16.2.6.4. SWOT Analysis

            16.2.7. Mount Sinai Hospital

                16.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.7.2. Company Financials

                16.2.7.3. Growth Strategies

                16.2.7.4. SWOT Analysis

            16.2.8. Tubingen University Hospital

                16.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.8.2. Company Financials

                16.2.8.3. Growth Strategies

                16.2.8.4. SWOT Analysis

            16.2.9. St. Mark's Hospital

                16.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.9.2. Company Financials

                16.2.9.3. Growth Strategies

                16.2.9.4. SWOT Analysis

            16.2.10. Apollo Hospitals Enterprise Ltd.

                16.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.10.2. Company Financials

                16.2.10.3. Growth Strategies

                16.2.10.4. SWOT Analysis

            16.2.11. Other Prominent Players

                16.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.11.2. Company Financials

                16.2.11.3. Growth Strategies

                16.2.11.4. SWOT Analysis

    List of Tables

    Table 01: Global Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Type, 2017–2031

    Table 02: Global Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 03: Global Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017–2031

    Table 04: Global Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Medication, 2017–2031

    Table 05: Global Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Surgery, 2017–2031

    Table 06: Global Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Indication, 2017–2031

    Table 07: Global Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Region, 2017–2031

    Table 08: North America Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Country, 2017–2031

    Table 09: North America Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Type, 2017–2031

    Table 10: North America Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 11: North America Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017–2031

    Table 12: North America Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Medication, 2017–2031

    Table 13: North America Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Surgery, 2017–2031

    Table 14: North America Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Indication, 2017–2031

    Table 15: Europe Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 16: Europe Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Type, 2017–2031

    Table 17: Europe Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 18: Europe Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017–2031

    Table 19: Europe Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Medication, 2017–2031

    Table 20: Europe Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Surgery, 2017–2031

    Table 21: Europe Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Indication, 2017–2031

    Table 22: Asia Pacific Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 23: Asia Pacific Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Type, 2017–2031

    Table 24: Asia Pacific Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 25: Asia Pacific Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017–2031

    Table 26: Asia Pacific Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Medication, 2017–2031

    Table 27: Asia Pacific Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Surgery, 2017–2031

    Table 28: Asia Pacific Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Indication, 2017–2031

    Table 29: Latin America Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 30: Latin America Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Type, 2017–2031

    Table 31: Latin America Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 32: Latin America Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017–2031

    Table 33: Latin America Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Medication, 2017–2031

    Table 34: Latin America Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Surgery, 2017–2031

    Table 35: Latin America Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Indication, 2017–2031

    Table 36: Middle East & Africa Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 37: Middle East & Africa Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Type, 2017–2031

    Table 38: Middle East & Africa Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 39: Middle East & Africa Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017–2031

    Table 40: Middle East & Africa Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Medication, 2017–2031

    Table 41: Middle East & Africa Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Surgery, 2017–2031

    Table 42: Middle East & Africa Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Indication, 2017–2031

    List of Figures

    Figure 01: Global Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, 2017–2031

    Figure 02: Global Recto-vaginal Fistula Treatment Market Value Share, by Type, 2020

    Figure 03: Global Recto-vaginal Fistula Treatment Market Value Share, by Indication, 2020

    Figure 04: Global Recto-vaginal Fistula Treatment Market Value Share, by End-user, 2020

    Figure 05: Global Recto-vaginal Fistula Treatment Market Value Share, by Treatment, 2020

    Figure 06: Global Recto-vaginal Fistula Treatment Market Value Share Analysis, by Type, 2020 and 2031

    Figure 07: Global Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Type, 2021–2031

    Figure 08: Global Recto-vaginal Fistula Treatment Market Revenue (US$ Mn), by High Recto-vaginal Fistula, 2017–2031

    Figure 09: Global Recto-vaginal Fistula Treatment Market Revenue (US$ Mn), by Low Recto-vaginal Fistula, 2017–2031

    Figure 10: Global Recto-vaginal Fistula Treatment Market Revenue (US$ Mn), by Midzone Fistula, 2017–2031

    Figure 11: Global Recto-vaginal Fistula Treatment Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 12: Global Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 13: Global Recto-vaginal Fistula Treatment Market Revenue (US$ Mn), by Hospitals, 2017–2031

    Figure 14: Global Recto-vaginal Fistula Treatment Market Revenue (US$ Mn), by Ambulatory Surgical Centers, 2017–2031

    Figure 15: Global Recto-vaginal Fistula Treatment Market Revenue (US$ Mn), by Others, 2017–2031

    Figure 16: Global Recto-vaginal Fistula Treatment Market Value Share Analysis, by Treatment, 2020 and 2031

    Figure 17: Global Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Treatment, 2021–2031

    Figure 18: Global Recto-vaginal Fistula Treatment Market Revenue (US$ Mn), by Medication, 2017–2031

    Figure 19: Global Recto-vaginal Fistula Treatment Market Revenue (US$ Mn), by Surgery, 2017–2031

    Figure 20: Global Recto-vaginal Fistula Treatment Market Value Share Analysis, by Indication, 2020 and 2031

    Figure 21: Global Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Indication 2021–2031

    Figure 22: Global Recto-vaginal Fistula Treatment Market Revenue (US$ Mn), by Crohn's Disease, 2017–2031

    Figure 23: Global Recto-vaginal Fistula Treatment Market Revenue (US$ Mn), by Delivery-related Injuries, 2017–2031

    Figure 24: Global Recto-vaginal Fistula Treatment Market Revenue (US$ Mn), by Cancerous Tumor Treatment, 2017–2031

    Figure 25: Global Recto-vaginal Fistula Treatment Market Revenue (US$ Mn), by Delivery-related Injuries, 2017–2031

    Figure 26: Global Recto-vaginal Fistula Treatment Market Value Share Analysis, by Region, 2020 and 2031

    Figure 27: Global Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Region, 2021–2031

    Figure 28: North America Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 29: North America Recto-vaginal Fistula Treatment Market Value Share, by Country, 2020–2031

    Figure 30: North America Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Country, 2021–2031

    Figure 31: North America Recto-vaginal Fistula Treatment Market Value Share Analysis, by Type, 2020 and 2031

    Figure 32: North America Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Type, 2021–2031

    Figure 33: North America Recto-vaginal Fistula Treatment Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 34: North America Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 35: North America Recto-vaginal Fistula Treatment Market Value Share Analysis, by Treatment, 2020 and 2031

    Figure 36: North America Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Treatment, 2021–2031

    Figure 37: North America Recto-vaginal Fistula Treatment Market Value Share Analysis, by Indication, 2020 and 2031

    Figure 38: North America Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Indication 2021–2031

    Figure 39: Europe Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 40: Europe Recto-vaginal Fistula Treatment Market Value Share, by Country/Sub-region, 2020–2031

    Figure 41: Europe Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

    Figure 42: Europe Recto-vaginal Fistula Treatment Market Value Share Analysis, by Type, 2020 and 2031

    Figure 43: Europe Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Type, 2021–2031

    Figure 44: Europe Recto-vaginal Fistula Treatment Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 45: Europe Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 46: Europe Recto-vaginal Fistula Treatment Market Value Share Analysis, by Treatment, 2020 and 2031

    Figure 47: Europe Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Treatment, 2021–2031

    Figure 48: Europe Recto-vaginal Fistula Treatment Market Value Share Analysis, by Indication, 2020 and 2031

    Figure 49: Europe Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Indication 2021–2031

    Figure 50: Asia Pacific Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 51: Asia Pacific Recto-vaginal Fistula Treatment Market Value Share, by Country/Sub-region, 2020–2031

    Figure 52: Asia Pacific Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

    Figure 53: Asia Pacific Recto-vaginal Fistula Treatment Market Value Share Analysis, by Type, 2020 and 2031

    Figure 54: Asia Pacific Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Type, 2021–2031

    Figure 55: Asia Pacific Recto-vaginal Fistula Treatment Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 56: Asia Pacific Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 57: Asia Pacific Recto-vaginal Fistula Treatment Market Value Share Analysis, by Treatment, 2020 and 2031

    Figure 58: Asia Pacific Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Treatment, 2021–2031

    Figure 59: Asia Pacific Recto-vaginal Fistula Treatment Market Value Share Analysis, by Indication, 2020 and 2031

    Figure 60: Asia Pacific Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Indication 2021–2031

    Figure 61: Latin America Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 62: Latin America Recto-vaginal Fistula Treatment Market Value Share, by Country/Sub-region, 2020–2031

    Figure 63: Latin America Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

    Figure 64: Latin America Recto-vaginal Fistula Treatment Market Value Share Analysis, by Type, 2020 and 2031

    Figure 65: Latin America Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Type, 2021–2031

    Figure 66: Latin America Recto-vaginal Fistula Treatment Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 67: Latin America Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 68: Latin America Recto-vaginal Fistula Treatment Market Value Share Analysis, by Treatment, 2020 and 2031

    Figure 69: Latin America Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Treatment, 2021–2031

    Figure 70: Latin America Recto-vaginal Fistula Treatment Market Value Share Analysis, by Indication, 2020 and 2031

    Figure 71: Latin America Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Indication 2021–2031

    Figure 72: Middle East & Africa Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 73: Middle East & Africa Recto-vaginal Fistula Treatment Market Value Share, by Country/Sub-region, 2020–2031

    Figure 74: Middle East & Africa Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

    Figure 75: Middle East & Africa Recto-vaginal Fistula Treatment Market Value Share Analysis, by Type, 2020 and 2031

    Figure 76: Middle East & Africa Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Type, 2021–2031

    Figure 77: Middle East & Africa Recto-vaginal Fistula Treatment Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 78: Middle East & Africa Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 79: Middle East & Africa Recto-vaginal Fistula Treatment Market Value Share Analysis, by Treatment, 2020 and 2031

    Figure 80: Middle East & Africa Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Treatment, 2021–2031

    Figure 81: Middle East & Africa Recto-vaginal Fistula Treatment Market Value Share Analysis, by Indication, 2020 and 2031

    Figure 82: Middle East & Africa Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Indication 2021–2031

    Figure 83: Global Recto-vaginal Fistula Treatment Market Share, by Company, 2020

Copyright © Transparency Market Research, Inc. All Rights reserved